Genedata, a Danaher company, announced that it has integrated NVIDIA’s RFD4-Proteina protein‑binder design model into its AI‑driven discovery workflows. The model was first shown at NVIDIA’s GTC conference in Berlin, and Genedata is among the earliest partners to make it available for production use. Researchers can define target properties in Genedata’s AI co‑scientist, generate candidate binders with the model, and feed laboratory results back into the system for continuous learning.
Why it matters
Biopharma teams can now run AI‑generated binder designs through their normal lab workflow, speeding up candidate screening while keeping full data traceability.
